{"Symbol": "FLXN", "AssetType": "Common Stock", "Name": "Flexion Therapeutics, Inc", "Description": "Flexion Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. It offers ZILRETTA, an intra-articular injection for the management of osteoarthritis (OA) pain of the knee in the United States. The company also develops FX201 a gene therapy product candidate designed to stimulate the production of an anti-inflammatory protein, interleukin-1 receptor antagonist for pain relief from OA of the knee. Flexion Therapeutics, Inc. was founded in 2007 and is headquartered in Burlington, Massachusetts.", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "Healthcare", "Industry": "Drug ManufacturersSpecialty & Generic", "Address": "10 Mall Road, Burlington, MA, United States, 01803", "FullTimeEmployees": "288", "FiscalYearEnd": "December", "LatestQuarter": "2020-06-30", "MarketCapitalization": "566438592", "EBITDA": "-150407008", "PERatio": "None", "PEGRatio": "0", "BookValue": "0.335", "DividendPerShare": "None", "DividendYield": "0", "EPS": "-4.278", "RevenuePerShareTTM": "2.055", "ProfitMargin": "-1.7424", "OperatingMarginTTM": "-1.5256", "ReturnOnAssetsTTM": "-0.3064", "ReturnOnEquityTTM": "-4.8691", "RevenueTTM": "81018000", "GrossProfitTTM": "62997000", "DilutedEPSTTM": "-3.581", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "-0.089", "AnalystTargetPrice": "20.75", "TrailingPE": "0", "ForwardPE": "0", "PriceToSalesRatioTTM": "5.3907", "PriceToBookRatio": "33.0745", "EVToRevenue": "7.0637", "EVToEBITDA": "0", "Beta": "2.0555", "52WeekHigh": "22.98", "52WeekLow": "5.01", "50DayMovingAverage": "12.5656", "200DayMovingAverage": "11.5497", "SharesOutstanding": "49298400", "SharesFloat": "44102833", "SharesShort": "10070034", "SharesShortPriorMonth": "8706811", "ShortRatio": "16.27", "ShortPercentOutstanding": "0.21", "ShortPercentFloat": "0.2808", "PercentInsiders": "2.108", "PercentInstitutions": "96.5", "ForwardAnnualDividendRate": "0", "ForwardAnnualDividendYield": "0", "PayoutRatio": "0", "DividendDate": "None", "ExDividendDate": "None", "LastSplitFactor": "None", "LastSplitDate": "None"}